Brent Antone Uhrig

Title: Brent Antone Uhrig: Innovator in Pharmaceutical Compositions

Introduction

Brent Antone Uhrig is a notable inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating cancer. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Brent holds a patent for pharmaceutical compositions that include N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)-benzamide. This patent focuses on formulations that can be used in dosage forms and methods for treating subjects diagnosed with cancer. His work in this area highlights the potential for new therapeutic options in oncology.

Career Highlights

Brent is currently associated with Ignyta, Inc., a company dedicated to precision medicine in oncology. His role at Ignyta allows him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

Some of Brent's coworkers include Robert L. Orr and Kathryn Emily Colombo Pugh. Their collective expertise fosters a collaborative environment that drives forward-thinking solutions in cancer treatment.

Conclusion

Brent Antone Uhrig's work exemplifies the impact of innovation in pharmaceuticals, particularly in the fight against cancer. His patent and ongoing contributions at Ignyta, Inc. reflect a commitment to advancing medical science and improving patient outcomes.